Select Bibliography

Filter by any of these (after searching):

J Support Oncol

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 5 items

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)

Barton, D. L. , Atherton, P. J. , Bauer, B. A. , Moore, D. F., Jr ... - - J Support Oncol - 2011

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N01C5

Determination of Utility Scores for Control of Chemotherapy-Induced Nausea or Vomiting—CALGB 309801

Grunberg, S. M. , Weeks, J. , Magnan, W. F. , Herndon, J., 2nd ... - - J Support Oncol - 2009

Manuscript - Primary - Primary - Disparities - CALGB-309801

Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.

Jatoi, Aminah , Nguyen, Phuong L , Foster, Nathan , Sun, David ... - - J Support Oncol - 2007

Manuscript - Secondary - Primary - GI - NCCTG-N0242

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment Group study N04CA

Loprinzi, C. L. , Balcueva, E. P. , Liu, H. , Sloan, J. A. ... - - J Support Oncol - 2011

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N04CA

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB

Moraska, A. R. , Atherton, P. J. , Szydlo, D. W. , Barton, D. L. ... - - J Support Oncol - 2010

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N00CB